{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:27:13Z","timestamp":1791772033452,"version":"4.3.4"},"reference-count":47,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"crossref","award":["HHSO100201100023C"],"award-info":[{"award-number":["HHSO100201100023C"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"the National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["HHSN272200800041C"],"award-info":[{"award-number":["HHSN272200800041C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2023,3,4]]},"DOI":"10.1080\/14787210.2023.2170350","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T14:11:21Z","timestamp":1675347081000},"page":"235-242","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential"],"prefix":"10.1080","volume":"21","author":[{"given":"Andrew T.","family":"Russo","sequence":"first","affiliation":[{"name":"SIGA Technologies, Inc, Corvallis, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas W.","family":"Grosenbach","sequence":"additional","affiliation":[{"name":"SIGA Technologies, Inc, Corvallis, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kady M.","family":"Honeychurch","sequence":"additional","affiliation":[{"name":"SIGA Technologies, Inc, Corvallis, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Long","sequence":"additional","affiliation":[{"name":"SIGA Technologies, Inc, Corvallis, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis E.","family":"Hruby","sequence":"additional","affiliation":[{"name":"SIGA Technologies, Inc, Corvallis, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1977.0122"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020025"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1126\/science.345.6194.247"},{"key":"cit0004","first-page":"4","volume":"5","author":"Gellman B","year":"2002","journal-title":"The Washington Po st"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188453"},{"key":"cit0006","first-page":"1287","volume-title":"Smallpox and its eradication","author":"Fenner F","year":"1988"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.11.008"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007791"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.bmb.a011720"},{"key":"cit0010","unstructured":"CDC. 2022 monkeypox outbreak global map 2022 [cited 2023 Jan 10]. Available from: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html"},{"issue":"105","key":"cit0011","first-page":"37988","volume":"67","author":"United States Food and Drug Administration","year":"2002","journal-title":"Fed Regist"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.06.005"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7137e1"},{"key":"cit0014","unstructured":"A5418:StudyOf Tecovirimat For Human Monkeypox Virus (STOMP). The AIDS Clinical Trial Group. 2022 [cited 2023 Jan 10]. Available from: https:\/\/actgnetwork.org\/studies\/a5418-study-of-tecovirimat-for-human-monkeypox-virus-stomp\/"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.3390\/v2112409"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.11.27"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.20.13139-13149.2005"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.65.11.5910-5920.1991"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku545"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00879-06"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00678-09"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912134107"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.02.005"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00208-15"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.10.049"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy326"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00977-13"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00021-09"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01596-08"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.76.768"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705688"},{"key":"cit0032","unstructured":"TPOXX\u00ae (tecovirimat) [package insert]. Corvallis (OR): SIGA Technologies, Inc; 2018."},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1819791"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1177\/0192623307310945"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.417"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0967-6"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6710a5"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1567330"},{"issue":"5","key":"cit0039","first-page":"593","volume":"46","author":"Ladnyj ID","year":"1972","journal-title":"Bull World Health Organ"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.3201\/eid2505.190076"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.159.11.1022"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30537-7"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.38.1800509"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200422"},{"key":"cit0045","unstructured":"CDC. Demographics of patients receiving TPOXX for treatment of Mpox 2023 [updated December 21, 2022; cited 2023 Jan 10]. Available from: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/demographics-TPOXX.html"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.10.031"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1089\/bsp.2012.0037"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2023.2170350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T17:18:45Z","timestamp":1678123125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2023.2170350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,4]]}},"alternative-id":["10.1080\/14787210.2023.2170350"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2023.2170350","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}